Presentation is loading. Please wait.

Presentation is loading. Please wait.

Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma  Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji.

Published byCorey Morton Modified over 5 years ago

Similar presentations

Presentation on theme: "Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma  Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji."— Presentation transcript:

1 Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma 
Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji Yamazaki, MD, PhD, Takuro Kometani, MD, Yoshihiko Maehara, MD, PhD  The Annals of Thoracic Surgery  Volume 81, Issue 4, Pages (April 2006) DOI: /j.athoracsur Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 The relationship between the pack-year index (PYI) and the prognosis-proportion of pathologic stage in squamous cell carcinoma. (A) Survival curves of subgroups classified by smoking status. Patients with squamous cell carcinoma were classified to four subgroups according to their PYI, and the respective survival curves were statistically analyzed. (B) The proportion and number of patients with squamous cell carcinoma in the subgroups according to PYI were shown. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 The relationship between the pack-year index (PYI) and the prognosis-proportion of pathologic stage in adenocarcinoma. (A) Survival curves of subgroups classified by smoking status. Patients with adenocarcinoma were classified to four subgroups according to their PYI, and the respective survival curves were statistically analyzed. (B) The proportion and number of patients with adenocarcinoma in the subgroups according to PYI score were shown. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma  Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji."

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia  Takahiro Omori, MD, Michihiko Tajiri, MD, PhD, Tomohisa Baba, MD,

Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia  Takahiro Omori, MD, Michihiko Tajiri, MD, PhD, Tomohisa Baba, MD,
Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,

Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Collision Tumor of Esophagus: Report of Three Cases

Collision Tumor of Esophagus: Report of Three Cases
Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer  Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.

Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer  Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis  Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis  Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,
Prognostic Value of Different Lymph Node Staging Methods in Esophageal Squamous Cell Carcinoma After Esophagectomy  San-Gang Wu, MD, Feng-Yan Li, MD,

Prognostic Value of Different Lymph Node Staging Methods in Esophageal Squamous Cell Carcinoma After Esophagectomy  San-Gang Wu, MD, Feng-Yan Li, MD,
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
High Expression of Zinc-Binding Protein-89 Predicts Decreased Survival in Esophageal Squamous Cell Cancer  Shu-Mei Yan, MD, Hui-Ni Wu, MB, Fan He, MD,

High Expression of Zinc-Binding Protein-89 Predicts Decreased Survival in Esophageal Squamous Cell Cancer  Shu-Mei Yan, MD, Hui-Ni Wu, MB, Fan He, MD,
Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma

Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L
Operative Results and Outcomes in Children With Shone's Anomaly

Operative Results and Outcomes in Children With Shone's Anomaly
Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Similar presentations

Ads by Google